LKY-047
LKY-047, a Decursin derivative, is a potent and selective reversible competitive cytochrome P45022J2 (CYP2J2) inhibitor with an IC50 of 1.7 μM. LKY-047 is inactive against other human P450s, such as CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A[1].
Product Specifications
CAS Number
[1954681-29-8]
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lky-047.html
Concentration
10mM
Purity
99.94
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(O[C@H]1CC(C=C(C=CC(O2)=O)C2=C3)=C3OC1(C)C)/C=C/C4=CC=C([N+]([O-])=O)C=C4
Molecular Formula
C23H19NO7
Molecular Weight
421.40
References & Citations
[1]Nguyen Minh Phuc, et al. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2. Drug Metab Dispos. 2017 Jul;45 (7) :765-769.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
FOSL2, CT (FOSL2, FRA2, Fos-related antigen 2) (APC) discontinued
FITC-Linked Polyclonal Antibody to Microfibrillar Associated Protein 5 (MFAP5)
FITC-Linked Polyclonal Antibody to Microfibrillar Associated Protein 5 (MFAP5)
FITC-Linked Polyclonal Antibody to Microfibrillar Associated Protein 5 (MFAP5)